Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Relay Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Relay Therapeutics Inc. June 9, 202682.2%
-
Sarepta Therapeutics Inc. June 4, 202698.8%
-
Arrowhead Pharmaceuticals Inc. March 12, 202583.3%
-
Sarepta Therapeutics Inc. June 6, 202498.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 16, 2025 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,819 | — | — |
| Dec 7, 2025 | Sarepta Therapeutics Inc. | Grant or award | +50,000 | — | — |
| Dec 7, 2025 | Sarepta Therapeutics Inc. | Grant or award | +50,000 | — | — |
| Dec 7, 2025 | Sarepta Therapeutics Inc. | Grant or award | +73,001 | — | — |
| Dec 7, 2025 | Sarepta Therapeutics Inc. | Grant or award | +96,541 | — | — |
| Dec 7, 2025 | Sarepta Therapeutics Inc. | Grant or award | +269,542 | — | — |
| Feb 6, 2025 | Arrowhead Pharmaceuticals Inc. | Grant or award | +38,396 | $20.09 | $771,376 |
| Nov 3, 2023 | Sarepta Therapeutics Inc. | Open-market purchase | +10,081 | $78.57 | $792,064 |
| Nov 3, 2023 | Sarepta Therapeutics Inc. | Open-market purchase | +11,060 | $79.70 | $881,482 |
| Nov 3, 2023 | Sarepta Therapeutics Inc. | Open-market purchase | +3,884 | $80.33 | $312,002 |
| Nov 3, 2023 | Sarepta Therapeutics Inc. | Open-market purchase | +200 | $81.26 | $16,252 |
Questions about Douglas S. Ingram
What boards is Douglas S. Ingram on?
Douglas S. Ingram sits on the boards of Arrowhead Pharmaceuticals Inc., Relay Therapeutics Inc. and Sarepta Therapeutics Inc.
Has Douglas S. Ingram been a CEO?
Yes — Douglas S. Ingram was CEO of Sarepta Therapeutics Inc. (Until July 2026).
How long has Douglas S. Ingram served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.